| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.12 | 0.5 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |